AJP - Renal Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol (February 25, 2009). doi:10.1152/ajprenal.90766.2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
296/6/F1484    most recent
90766.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gwathmey, T. M.
Right arrow Articles by Chappell, M. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gwathmey, T. M.
Right arrow Articles by Chappell, M. C.
Submitted on December 24, 2008
Revised on January 29, 2009
Accepted on February 18, 2009

NUCLEAR ANGIOTENSIN II - TYPE 2 (AT2) RECEPTORS ARE FUNCTIONALLY LINKED TO NITRIC OXIDE PRODUCTION

TanYa M. Gwathmey1*, Hossam A Shaltout2, Karl D Pendergrass1, Nancy T Pirro, Jorge P. Figueroa1, James C. Rose1, Debra I. Diz1, and Mark C. Chappell1

1 Wake Forest University School of Medicine
2 Wake Forest University, School of Medicine

* To whom correspondence should be addressed. E-mail: tgwathme{at}wfubmc.edu.

Expression of nuclear angiotensin II type 1 (AT1) receptors in rat kidney provides further support for the concept of an intracellular renin-angiotensin system (iRAS). Thus, we examined the cellular distribution of renal Ang II receptors in sheep to determine the existence and functional roles of intracellular Ang receptors in higher order species. Receptor binding was performed using the non-selective Ang II antagonist 125I-[Sar1,Thr8]-Ang II (125I-Sarthran) with the AT1 antagonist Losartan (LOS) or the AT2 antagonist PD123319 (PD) in isolated nuclei (NUC) and plasma membrane (PM) fractions obtained by differential centrifugation or density gradient separation. In both fetal and adult sheep kidney, PD competed for the majority of cortical NUC (≥70%) and PM (≥80%) sites while LOS competition predominated in medullary NUC (≥75%) and PM (≥70%). Immunodetection with an AT2 antibody revealed a single ~42 kDa band in both NUC and PM extracts, suggesting a mature molecular form of the NUC receptor. Autoradiography for receptor subtypes localized AT2 in tubulointerstitium, AT1 in medulla and vasa recta, and both AT1 and AT2 in glomeruli. Treatment of NUC with the fluorescent NO detector DAF showed increased NO production with Ang II (1 nM), which was abolished by PD and L-NAME, but not LOS. Our studies demonstrate Ang II receptor subtypes are differentially expressed in ovine kidney, while nuclear AT2 receptors are functionally linked to NO production. These findings provide further evidence of a functional iRAS within the kidney, which may represent a therapeutic target for the regulation of blood pressure.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.